Conference Description

Emerging Challenges in Cardiology: 2006

November 18, 2006
Westin Fort Lauderdale
400 Corporate Drive
Fort Lauderdale, FL 33334
800-937-8461

Tell a friend about this conference

Download the brochure for this conference

See how attendees evaluated these conferences

CME Credits: 7.5*

Nonrefundable registration fee: $0.

Target Audience: Physicians, Nurse Practitioners, and Physician Assistants caring for patients with cardiovascular disease.

Program Summary:
Emerging Challenges in Cardiology: 2006 is a one day program covering recent advances in Cardiology. Key topics to be addressed will include: coronary artery disease risk factor management, device management of heart failure, valvular heart disease, medical and interventional management of acute coronary syndromes, and the evaluation and management of pulmonary hypertension.
The meeting will provide a review of cardiovascular medicine geared to practicing physicians. Nationally known faculty will present evolving issues and challenges relevant to clinical practice.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. Explain the favorable benefit to risk ratio of more aggressive statin therapy including reductions in myocardial infarction and stroke
2. Demonstrate that in the management of hypertension, achieving lower blood pressure is the most important factor to prevent cardiovascular events and review the evidence-based data for the current treatment of hypertension
3. Review epidemiology of anemia in heart failure and characterize cause and consequences of anemia in heart failure. Discuss the pilot studies that suggest that treatment of anemia with erythropoietic agents improves exercise capacity and clinical status, and discuss need for long-term trials to establish the safety and efficacy of erythropoietic agents in heart failure
4. Identify the important aspects in the diagnosis and management of pulmonary hypertension
5. Summarize clinical data comparing and contrasting the drug eluting stents available in the U.S. and explain the indications and safety issues of drug eluting stents
6. List the important aspects in the evaluation and management of acute coronary syndromes
7. Discuss recent advancements in the management of chronic ischemic heart disease
8. Apply the indications for defibrillator therapy for primary and secondary prevention of sudden cardiac death and for the use of cardiac resynchronization therapy for heart failure
9. Recognize pathophysiologic features of aortic and mitral valve disease, and understand current recommendations for surgical intervention and the evidence base supporting them
10. Recognize the emerging potential of CT coronary angiography in the diagnostic and prognostic assessment of CAD

Agenda:

7:30-7:50 am		Registration and Continental Breakfast
7:50-8:00		Welcome Remarks Jose R. Soler, MD
8:00-8:40		New Trials of Statins Bring New Federal Guidelines and New Clinical Challenges Charles Hennekens, MD
8:40-9:20		The use of Cardiac Devices in Heart Failure Juan Aranda, MD
9:20-10:00		Diagnosis and Treatment of Anemia in Heart Failure Stuart David Katz, MD
10:00-10:20		Break
10:20-11:00		Evaluation and Management of Acute Coronary Syndromes Marc Cohen, MD
11:00-11:40		Advances in PCI – Drug Eluting Stents Harry Phillips, MD
11:40-12:20		Advances in the Management of Chronic Ischemic Heart Disease Gervasio A. Lamas, MD
12:20-1:10		Lunch
1:10-1:50		The Advent of New Guidelines in the Management of Valvular Disease Robert O. Bonow, MD
1:50-2:30		The Surgical Management of Ischemic Mitral Regurgitation and of Atrial Fibrillation Harold Roberts, MD
2:30-3:10		Emerging Optimal Strategies for Prevention of Cardiovascular and Renal Events in the Hypertensive-Patient Robert A. Phillips, MD, PhD
3:10-3:30		Break
3:30-4:10		Diagnosis and Management of Pulmonary Arterial Hypertension Franck F. Rahaghi, MD
4:10-4:50		Role of Cardiac CT and CTA in the Evaluation of Coronary Disease Norbert Wilke, MD
4:50-5:00		Closing Remarks Jose R. Soler, MD

Faculty:
Juan Aranda, MD
Associate Professor of Medicine
University of Florida College of Medicine
Co-Director Heart Transplant and Heart Failure Program
Shands Hospital, University of Florida,
Director Heart Failure/Electrophysiology Fellowship Program

Robert Bonow, MD
Chief, Division of Cardiology
Northwestern University Medical School
Northwestern Memorial Hospital
Co-Director of the Northwestern Cardiovascular Institute

Marc Cohen, MD, FACC
Professor of Medicine, Mount Sinai School of Medicine, NY
Chief, Division of Cardiology, Newark Beth Israel Medical Center

Charles Hennekens, MD
Co-Director of Cardiovascular Research at MSMC-MHI
Professor of Medicine & Epidemiology and Public Health at the
University of Miami School of Medicine

Stuart David Katz, MD
Associate Professor of Medicine
Yale University School of Medicine
Director Yale Heart Failure and Heart Transplantation

Gervasio A. Lamas, MD
Associate Professor of Medicine
University of Miami School of Medicine
Director of Cardiovascular Research and Academic Affairs
Mount Sinai Medical Center

Harry R. Phillips, MD
Professor of Medicine
Duke University Medical Center, Durham, NC

Robert A. Phillips, MD, PhD
Chairman, Department of Medicine, Lenox Hill Hospital
Professor of Medicine, NYU School of Medicine
Associate Editor, Archives of Internal Medicine
New York, NY

Franck F. Rahaghi, MD, MHS, FCCP
Director, Pulmonary Hypertension Clinic
Pulmonary and Critical Care
Cleveland Clinic Florida at Weston

Harold Roberts, MD
South Florida Cardiovascular Surgical Associates
Florida Medical Center, Fort Lauderdale, Florida

Norbert Wilke, MD, FACC
Associate Professor of Radiology
Associate Professor of Medicine
Chief, Cardiovascular MR and CT
University of Florida

Program Planning Committee:
Jose R. Soler, MD and Gregg Sherman, MD

Activity Director: Alan Goodstat, LCSW

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 7.5 Prescribed credit(s) by the American Academy of Family Physicians. The AAFP invites comments on any activity that has been approved for AAFP CME credit. Please forward your comments on the quality of this activity to cmecomment@aafp.org.

This activity has been planned and implemented in accordance with the Essentials and Standards of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. UMMS is accredited by ACCME to provide continuing medical education for physicians. UMMS designates this continuing medical education activity for a maximum of 7.3 credit hours in Category I toward the Physicians Recognition Award of the American Medical Association. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.

Under the auspices of the University of Massachusetts Medical School Office of Continuing Education this offering meets the requirements for 8.8 contact hours, as specified by the Massachusetts Board of Registration in Nursing (244-CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spend in the educational activity.

This program was supported through educational grants from the following companies: Actelion, Amgen, AstraZeneca, ATS Medical, Bristol-Myers Squibb Company, Camelia Home Health, Comprehensive Home Care, Cordis, CV Therapeutics, Edwards, Sanofi-Aventis, Schering Plough, St. Jude, The Medicines Company.